Claudius Mahr, DO, FACC, FESC, FHFA, FRSM

Claudius Mahr, DO, FACC, FESC, FHFA, FRSM, serves as the Executive Director of the Institute for Advanced Cardiac Care and the System Director of Heart Failure at Medical City Healthcare. In this significant leadership position, he plays a crucial role in directing the future of cardiac care across a network comprising 21 hospitals. Balancing a demanding dual responsibility, he dedicates half of his time to direct patient care while simultaneously managing extensive administrative and strategic initiatives throughout the healthcare system. Located at Medical City Heart Hospital in Dallas, Texas, Dr. Mahr specializes in the thorough management of patients with advanced cardiovascular disorders, including various types of heart failure and cardiomyopathy. His methodology incorporates the latest advancements in medical, surgical, and device-oriented therapies, ranging from innovative pharmacological treatments to mechanical circulatory support and heart transplantation. Esteemed for his ability to handle the most complex cardiac cases, his clinical emphasis is on intricate heart failure syndromes and high-risk patients. This specialized care positions him among a select group of physicians adept at navigating the complexities associated with end-stage heart disease. Dr. Mahr's proficiency extends far beyond clinical practice. He is a Fellow of the American College of Cardiology, the European Society of Cardiology, the Heart Failure Association, and the Royal Society of Medicine. He remains an influential figure in the global cardiovascular arena through his active participation in the International Society for Heart and Lung Transplantation. Currently, he holds the position of President-Elect of the American Society for Artificial Internal Organs (ASAIO), further underscoring his impact on the advancement of cardiac innovations. With an impressive academic portfolio, Dr. Mahr has contributed over 125 peer-reviewed articles, book chapters, and manuscripts. His research and insights continue to influence evidence-based practices and motivate peers through presentations at various esteemed national and international medical conferences. Dr. Mahr is board certified in both Cardiology and Advanced Heart Failure and Transplant Cardiology by the National Board of Physicians and Surgeons. He embodies the convergence of clinical excellence, visionary leadership, and academic contribution. As heart disease persists as a primary cause of mortality globally, his commitment to enhancing care is not only timely but also transformative. An internationally acknowledged authority in his field, Dr. Mahr is a physician-scientist who serves on multiple scientific advisory boards and steering committees, as well as being an invited lecturer at numerous prestigious national and international scientific gatherings.